Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: Preliminary observations

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 95, Issue 6, 2003, Pages 710-716

  Tsai, Chung Hung ^a   Hsieh, Yih Shou ^b   Yang, Shun Fa ^b   Chou, Ming Yung ^b   Chang, Yu Chao ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; PROTEIN KINASE C INHIBITOR;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CLINICAL ARTICLE; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUTH CANCER; MOUTH MUCOSA; ORAL BIOPSY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SUPERNATANT; TISSUE CULTURE; ZYMOGRAPHY;

EID: 0037660722     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2003.121     Document Type: Article

References (39)

1. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, et al. Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993;53:5365-9.
2. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reymoldes JJ, Murphy G. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 1995;309:299-306.
3. Kinoh H, Sato H, Tsunezuka Y, Takino T, Kawashima A, Okada Y, et al. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 1996;109:953-9.
4. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993;7:1434-41.
5. MacDongall JR, Matrician LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1995;14:351-62.
6. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990;9:289-303.
7. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1999;64:327-36.
8. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
9. Kubota S, Mitsudomi T, Yamada Y. Invasive human fibrosarcoma DNA mediated induction of a 92 kDa gelatinase/type IV collagenase lead to an invasive phenotype. Biochem Biophys Res Commun 1991;181:1539-47.
10. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, et al. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992;141:389-96.
11. Powis G, Albert DS. Inhibiting intracellular signaling as a strategy for cancer chemoprevention. Eur J Cancer 1994;30A:1138-44.
12. Chang YC, Tsai CH, Tai KW, Yang SH, Chou MY, Lii CK. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 2002;38:425-30.
13. Wong DY, Chang KW, Chen CF, Chang RC. Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas-OC1 and OC2. J Oral Maxillofac Surg 1990;48:385-90.
14. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerized substrates. J Anal Chem 1980;102:196-202.
15. O'Grady RL, Nethery A, Hunter N. A fluorescent screening assay for collagenase using collagen labeled with L-methoxy-2,4-diphenyl-3(2H)furanone. Anal Biochem 1984;140:490-4.
16. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 2002;38:195-200.
17. Pickett KL, Harber GJ, DeCarlo AA, Louis P, Shaneyfelt S, Windsor LJ, et al. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro. J Dent Res 1999;78:1354-61.
18. Hong SD, Hong SP, Lee JI, Lim CY. Expression of matrix metalloproteinases-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 2000;36:207-13.
19. Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 1992;21:261-4.
20. Shiau YY, Kwan HW. Submucous fibrosis in Taiwan. Oral Surg Oral Med Oral Pathol 1979;47:453-7.
21. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationships with betel nut chewing: a preliminary report. J Formos Med Assoc 1976;75:497-505.
22. Parsonnent J. Molecular mechanisms for inflammation-promoted pathogenesis of cancer - The Sixteenth International Symposium of the Sapporo Cancer Seminar. Cancer Res 1997;57:3620-4.
23. Chang YC, Yang SF, Hsieh YS. Regulation of matrix metalloproteinases-2 production by cytokines and pharmacological agents in human pulp cell cultures. J Endod 2001;27:679-82.
24. Chang YC, Lai CC, Yang SF, Chan Y, Hsieh YS. Stimulation of matrix metalloproteinases by black-pigmented Bacteroides in human pulp and periodontal ligament cell cultures. J Endod 2002;28:90-3.
25. Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS. Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J Periodontal Res 2002;37:196-203.
26. Jeng JH, Ho YS, Chan CP, Wang YJ, Hahn LJ, Lei D, et al. Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human keratinocytes. Carcinogenesis 2000;21:1365-70.
27. Tsai CH, Chou MY, Chang YC. The upregulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med (In press).
28. Kylmaniemi M, Oikarinen A, Oikavinen K, Salo T. Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human normal mucosal and malignant cells. J Dent Res 1996;75:919-26.
29. Makela M, Larjava H, Pirila E, Maisi P, Salo T, Sorsa T, et al. Matrix metalloproteinases 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 1999;251:67-78.
30. Bennett JH, Morgan MJ, Whawell SA, Atkin P, Roblin P, Furness J, et al. Metalloproteinase expression in normal and malignant oral keratinocytes: stimulation of MMP-2 and -9 byscatter factor. Eur J Oral Sci 2000;108:281-91.
31. Zinber BL, Turner MA, Palefsky JM, Banda MJ, Kramex RH. Type I collagen degradation by invasive oral squamous cell carcinoma. Oral Oncol 2000;36:365-72.
32. Tang DG, Honn KV. Role of protein kinase C and phosphates in 12(s)-HETE-induced tumor cell cytoskeletal reorganization. Adv Exp Med Biol 1997;400:349-61.
33. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go6976. J Biol Chem 1993;268:9194-7.
34. Kawamoto S, Hidaka H. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun 1984;125:258-64.
35. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 1986;135:397-402.
36. Caponigro F, French RC, Kaye SB. Protein kinase C: a worthwhile target for anticancer drugs? Anticancer Drugs 1997;8:26-33.
37. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984;308:693-8.
38. Thavasu T, Propper D, McDonald A, Dobbs N, Ganesan T, Talbot D, et al. The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients. Cancer Res 1999;59:3980-4.
39. Wilson WH, Sorbara L, Figg WD, Mont EK, Sausville E, Warren KE, et al. Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm. Clin Cancer Res 2000;6:415-21.